Stocksigma LogoStocksigma Logo

API Holdings Directly Vests 51.02% Stake in Thyrocare Post-Amalgamation

API Holdings has directly acquired an 8,12,00,000 equity shareholding (51.02% of paid-up capital, 50.87% diluted) in Thyrocare Technologies following the

API Holdings Directly Vests 51.02% Stake in Thyrocare Post-Amalgamation

Thyrocare Technologies Ltd 路 Acquisition/ Disposal of Shares 路 04 Sept 2026, 8:29 pm

API Holdings Directly Vests 51.02% Stake in Thyrocare Post-Amalgamation API Holdings has directly acquired an 8,12,00,000 equity shareholding (51.02% of paid-up capital, 50.87% diluted) in Thyrocare Technologies following the NCLT-sanctioned merger of Docon Technologies into API Holdings. The scheme became effective on 3rd Sep'26 upon filing with the RoC, following NCLT approval on 31st Aug'26. As Docon stands amalgamated, its entire Thyrocare stake transferred to API Holdings by operation of law, resulting in no change in the overall promoter group aggregate shareholding.

Original exchange filing (PDF)

More announcements from Thyrocare Technologies Ltd

All Thyrocare Technologies Ltd announcements